| Dr Jillian L Boyd, OD | |
|
375 Barclay Cir, Rochester Hills, MI 48307 | |
| (248) 852-3636 | |
| Not Available |
| Full Name | Dr Jillian L Boyd |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 375 Barclay Cir, Rochester Hills, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134612450 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005123 (Michigan) | Primary |
| Provider Name | Millman Derr Center For Eye Care Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326238395 PECOS PAC ID: 6608772181 Enrollment ID: O20031208000648 |
News Archive
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.
Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.
Researchers in the U.S. and U.K. are conducting an ongoing investigation of the cognitive effect of fetal exposure across four commonly used antiepileptic drugs (AEDs) as part of an NIH-funded Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study. An early NEAD analysis found that fetal exposure to valproate impairs IQ at age three.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments.
› Verified 7 days ago
| Provider Name | Fraser Optical Clinic, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447326244 PECOS PAC ID: 6103841846 Enrollment ID: O20051011001038 |
News Archive
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.
Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.
Researchers in the U.S. and U.K. are conducting an ongoing investigation of the cognitive effect of fetal exposure across four commonly used antiepileptic drugs (AEDs) as part of an NIH-funded Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study. An early NEAD analysis found that fetal exposure to valproate impairs IQ at age three.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jillian L Boyd, OD 375 Barclay Cir, Rochester Hills, MI 48307-4511 Ph: (248) 852-3636 | Dr Jillian L Boyd, OD 375 Barclay Cir, Rochester Hills, MI 48307 Ph: (248) 852-3636 |
News Archive
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.
Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.
Researchers in the U.S. and U.K. are conducting an ongoing investigation of the cognitive effect of fetal exposure across four commonly used antiepileptic drugs (AEDs) as part of an NIH-funded Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study. An early NEAD analysis found that fetal exposure to valproate impairs IQ at age three.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments.
› Verified 7 days ago
Michael J Duerr, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 375 Barclay Cir, Rochester Hills, MI 48307 Phone: 248-852-3636 Fax: 248-852-3631 | |
2020 Vision Of Rochester Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3110 Walton Blvd, Rochester Hills, MI 48309 Phone: 248-375-0040 Fax: 248-375-1766 | |
Shelia Arlene Fuller, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 375 Barclay Cir, Rochester Hills, MI 48307 Phone: 248-852-3636 Fax: 248-852-3631 | |
Pearle Vision Doc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2915 Walton Blvd, Rochester Hills, MI 48309 Phone: 248-375-0022 Fax: 247-837-5024 | |
Robert Joseph Clark, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2861 S Rochester Rd, Rochester Hills, MI 48307 Phone: 248-852-5230 Fax: 248-852-2561 | |
Amy K Wozniak, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 137 S Livernois Rd, Rochester Hills, MI 48307 Phone: 248-652-0600 Fax: 248-652-2661 |